Actively Recruiting
Assessing the Impact of dTMS on Neural Targets Associated With Alcohol Use Disorder
Led by Stanford University · Updated on 2026-05-11
100
Participants Needed
1
Research Sites
193 weeks
Total Duration
On this page
Sponsors
S
Stanford University
Lead Sponsor
N
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate the efficacy of deep transcranial magnetic stimulation as a treatment for Veterans with Alcohol Use Disorder (AUD) to decrease the exceedingly high rate of relapse associated with this condition.
CONDITIONS
Official Title
Assessing the Impact of dTMS on Neural Targets Associated With Alcohol Use Disorder
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18-75
- Current DSM-5 diagnosis of moderate to severe Alcohol Use Disorder with at least 4 diagnostic symptoms
- Ability to obtain a Motor Threshold during screening
- Stable condition and environment to attend scheduled clinic visits
- Able to read, understand, and voluntarily sign informed consent
- Stable medication regimen for comorbid symptoms during treatment phase
- Fluent in English
You will not qualify if you...
- Contraindications for TMS or MRI such as pacemaker, cochlear implant, deep brain stimulation, metal near treatment coil, claustrophobia, pregnancy, or breastfeeding
- Medical or neurological conditions interfering with assessments or participation
- Unable to safely stop medications that increase seizure risk at least two weeks before treatment
- Current substance abuse except caffeine or nicotine
- Presence of mass lesion, cerebral infarct, active CNS disease, alcohol-related seizure, or seizure disorder
- Recent suicide attempt within 30 days or current suicidal plan or intent
- Severe vision, hearing, or hand movement impairments
- Traumatic brain injury with loss of consciousness over 10 minutes
- Use of benzodiazepines, neuroleptics, or medications altering seizure threshold
- Acute or unstable chronic illness
- Current or past bipolar disorder or psychosis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
VA Palo Alto Health Care System
Palo Alto, California, United States, 94304
Actively Recruiting
Research Team
S
Samantha J Ward, BS
CONTACT
E
Eileen G Fischer, BS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here